{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:10:30Z","timestamp":1790025030238,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005693","name":"Parent Project Muscular Dystrophy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymthe.2019.12.011","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T20:28:51Z","timestamp":1578601731000},"page":"845-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"28","author":[{"given":"Nalinda B.","family":"Wasala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakmini P.","family":"Wasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Niranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal J.","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.12.011_bib1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/cdd.2015.65","article-title":"Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy","volume":"22","author":"Burr","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2019.12.011_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/genes8040108","article-title":"Dystrophic cardiomyopathy\u2014potential role of calcium in pathogenesis, treatment and novel therapies","volume":"8","author":"Johnstone","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2019.12.011_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2019.12.011_bib4","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/erm.2014.17","article-title":"Dysregulation of calcium homeostasis in muscular dystrophies","volume":"16","author":"Vallejo-Illarramendi","year":"2014","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.20745","article-title":"SERCA pump isoforms: their role in calcium transport and disease","volume":"35","author":"Periasamy","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.12.011_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mus.20512","article-title":"Sarcoplasmic reticulum: the dynamic calcium governor of muscle","volume":"33","author":"Rossi","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.12.011_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","article-title":"Systemic delivery of adeno-associated viral vectors","volume":"21","author":"Duan","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/hum.2018.012","article-title":"Micro-dystrophin gene therapy goes systemic in Duchenne muscular dystrophy patients","volume":"29","author":"Duan","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2019.12.011_bib12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddp015","article-title":"Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice","volume":"18","author":"Li","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.12.011_bib13","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1093\/hmg\/ddu029","article-title":"Partial restoration of cardiac function with \u0394PDZ nNOS in aged mdx model of Duchenne cardiomyopathy","volume":"23","author":"Lai","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.12.011_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/path.2799","article-title":"Nitrosative stress elicited by nNOS\u03bc delocalization inhibits muscle force in dystrophin-null mice","volume":"223","author":"Li","year":"2011","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib15","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1073\/pnas.95.25.15090","article-title":"Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle","volume":"95","author":"Thomas","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.12.011_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","article-title":"Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin\/utrophin expression","volume":"102","author":"Bostick","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.12.011_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mus.21763","article-title":"Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy","volume":"42","author":"Bostick","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.12.011_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41551-018-0320-0","article-title":"CRISPR alleviates muscular dystrophy in dogs","volume":"2","author":"Duan","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2019.12.011_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","article-title":"CRISPR correction of Duchenne muscular dystrophy","volume":"70","author":"Min","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne\u2019s muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ceca.2018.10.004","article-title":"Role of STIM1\/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease","volume":"76","author":"Michelucci","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ymthe.2019.12.011_bib24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/clinchem\/28.7.1482","article-title":"Verapamil and calcium-stimulated enzyme efflux from skeletal muscle","volume":"28","author":"Anand","year":"1982","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.ymthe.2019.12.011_bib25","first-page":"CD004571","article-title":"Calcium antagonists for Duchenne muscular dystrophy","author":"Phillips","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymthe.2019.12.011_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1096\/fj.201700182RRR","article-title":"Ryanodine channel complex stabilizer compound S48168\/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy","volume":"32","author":"Capogrosso","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2019.12.011_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm739","article-title":"Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in\u00a0vivo cardiac rAAV gene delivery","volume":"8","author":"Hoshijima","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41467-017-01146-7","article-title":"Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice","volume":"8","author":"Voit","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.12.011_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2018.09.039","article-title":"Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition","volume":"505","author":"Tanihata","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2019.12.011_bib30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI43844","article-title":"Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle","volume":"121","author":"Goonasekera","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2019.12.011_bib31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1089\/hum.2010.077","article-title":"Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage","volume":"21","author":"Morine","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib32","doi-asserted-by":"crossref","first-page":"C699","DOI":"10.1152\/ajpcell.00341.2014","article-title":"SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models","volume":"308","author":"M\u00e1zala","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1479-5876-9-132","article-title":"SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice","volume":"9","author":"Shin","year":"2011","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ymthe.2019.12.011_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2019.12.011_bib35","first-page":"2633","article-title":"Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype","volume":"25","author":"Wasala","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.12.011_bib36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/gt.2012.10","article-title":"Progress in gene therapy of dystrophic heart disease","volume":"19","author":"Lai","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib37","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary cardiac issues in Duchenne muscular dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.12.011_bib38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2019.12.011_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.12.011_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J.\u00a0Card. Fail."},{"key":"10.1016\/j.ymthe.2019.12.011_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/hum.2008.058","article-title":"Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice","volume":"19","author":"Bostick","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0074-7696(08)60158-8","article-title":"Characteristics of skeletal muscle in mdx mutant mice","volume":"191","author":"De la Porte","year":"1999","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib43","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2353\/ajpath.2008.071042","article-title":"Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein","volume":"172","author":"Li","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib44","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1093\/hmg\/ddr433","article-title":"Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice","volume":"20","author":"Judge","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.12.011_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2044-5040-1-32","article-title":"Transgenic overexpression of \u03b3-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice","volume":"1","author":"Baltgalvis","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2019.12.011_bib46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/mus.20920","article-title":"Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C","volume":"37","author":"Bogdanovich","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.12.011_bib47","series-title":"Muscle Gene Therapy","first-page":"291","article-title":"Considerations on preclinical neuromuscular disease gene therapy design","author":"Duan","year":"2019"},{"key":"10.1016\/j.ymthe.2019.12.011_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2016.11.011","article-title":"Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy","volume":"102","author":"Wasala","year":"2017","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1073\/pnas.96.1.220","article-title":"Severe cardiomyopathy in mice lacking dystrophin and MyoD","volume":"96","author":"Megeney","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.12.011_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-61779-343-1_15","article-title":"Recombinant adeno-associated viral vector production and purification","volume":"798","author":"Shin","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib51","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1093\/hmg\/ddt112","article-title":"Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy","volume":"22","author":"Wasala","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.12.011_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/mt.2008.264","article-title":"Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged dmx mice","volume":"17","author":"Bostick","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-61737-982-6_5","article-title":"Monitoring murine skeletal muscle function for muscle gene therapy","volume":"709","author":"Hakim","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-61737-982-6_6","article-title":"Phenotyping cardiac gene therapy in mice","volume":"709","author":"Bostick","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12265-015-9669-6","article-title":"Standard operating procedures (SOPs) for evaluating the heart in preclinical studies of Duchenne muscular dystrophy","volume":"9","author":"Duan","year":"2016","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ymthe.2019.12.011_bib56","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/mt.2011.154","article-title":"AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice","volume":"19","author":"Bostick","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.12.011_bib57","first-page":"H747","article-title":"Measurement of heart rate and Q-T interval in the conscious mouse","volume":"274","author":"Mitchell","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymthe.2019.12.011_bib58","first-page":"1239","article-title":"Cardiomyopathies associated with muscular dystrophies","volume":"Vol. 2","author":"Nigro","year":"2004"},{"key":"10.1016\/j.ymthe.2019.12.011_bib59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI108522","article-title":"Hemodynamic determinants of the time-course of fall in canine left ventricular pressure","volume":"58","author":"Weiss","year":"1976","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2019.12.011_bib60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jss.2008.05.002","article-title":"Body surface area prediction in normal, hypermuscular, and obese mice","volume":"153","author":"Cheung","year":"2009","journal-title":"J.\u00a0Surg. Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162030006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162030006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T12:11:28Z","timestamp":1727698288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162030006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S152500162030006X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.12.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737268339.793570462","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}